ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1080

Electronic Consults to Rheumatology: A One-Year Analysis of Referral Outcomes and Trends in Access

Jeanne Gosselin1, Brendan Thoms2, Bonita Libman3, Tessalyn Morrison3, George McLane2 and Teresa Fama4, 1University of Vermont Medical Center, Waterbury, VT, 2University of Vermont Medical Center, South Burlington, VT, 3University of Vermont Medical Center, Burlington, VT, 4Univ of Vermont Health Network-Central Vermont Medical Center, Jericho, VT

Meeting: ACR Convergence 2024

Keywords: Access to care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Access to rheumatologic care is severely limited at our academic medical center with wait times of 9 months or longer for routine new patient visits. Prior examination of joint pain referrals to our rheumatology clinic highlighted important delays in the evaluation of new inflammatory arthritis and incomplete or inappropriate testing at the time of referral, hindering effective triage. We implemented electronic consults (e-consults) to rheumatology in October 2022 as one of several interventions to improve access. In this first phase of the project, we described the number of e-consults by question and outcome, and the turnaround time from placement to resolution. The second phase of the project will examine changes in access following e-consult implementation compared to pre-intervention data.

Methods: E-consult data were collected using Epic SQL reporting tools. Eligible records included all adult (age ≥ 18) e-consults to the rheumatology division between October 1, 2022 and September 30, 2023. The panel of e-consult questions, shown in Figure 1, was available only to physicians and advanced practice providers within the health network via the electronic medical record. There were three possible e-consult outcomes: completed (e-consult question answered), converted (question deemed too complex for e-consult with in-person evaluation recommended), or declined (question inappropriate for rheumatology or incomplete information provided). Mean turnaround time (TAT) represented the time from e-consult placement to closure, expressed in days.

Results: A total of 509 rheumatology e-consults were received over the one-year period, with “Positive ANA” the most common consult question at 37%. “Other,” which included diverse clinical questions ranging from fatigue to interstitial lung disease, accounted for 26%, “Joint Pain” 23%, “Fibromyalgia” and “PMR” 6% each, and “Gout” 2% of total e-consults. E-consults for “Fibromyalgia” (n=32) had the highest completion rate at 91%, followed by “Positive ANA” (n=186) at 83%. “Joint Pain” (n=133) had the highest rate of conversion at 28% with 66% completed. E-consults for “Other” were declined at the highest rate (10%). Mean turnaround time for e-consults by outcome ranged from 0.61 days for completed to 0.98 days for declined.

Conclusion: E-consults will be an important tool in a multipronged approach to improve rheumatology access. Given the observed mean TAT of less than one day for all e-consults, we feel confident this intervention will achieve the primary aim of reduced wait times overall, defined as the time from placement of any type of rheumatology referral to any type of rheumatology visit (e-consult, in-person or telemedicine), when compared with historical data. This project provides essential data on referral trends to help establish future e-consult targets and to determine the institutional resources needed to support the initiative. Project data will also inform future iterations of our enhanced referral panels and identify areas for educational outreach.

Supporting image 1

Figure 1. E-consult by type.

Supporting image 2

Figure 2. E-consult outcomes.

Supporting image 3

Figure 3. Mean turnaround time (TAT) in days by consult outcome.

Disclosures: J. Gosselin: None; B. Thoms: None; B. Libman: American college of physicians, 12, Clinical Editor; T. Morrison: None; G. McLane: None; T. Fama: None.

To cite this abstract in AMA style:

Gosselin J, Thoms B, Libman B, Morrison T, McLane G, Fama T. Electronic Consults to Rheumatology: A One-Year Analysis of Referral Outcomes and Trends in Access [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/electronic-consults-to-rheumatology-a-one-year-analysis-of-referral-outcomes-and-trends-in-access/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/electronic-consults-to-rheumatology-a-one-year-analysis-of-referral-outcomes-and-trends-in-access/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology